Elevate your expectations. Demand more from your CDMO.
Recro®️ is the oral solid dose expert specializing in modified release formulations, including those for DEA controlled substances. No matter the scope of your project, we deliver — streamlining product formulation and manufacturing from concept to clinic to commercial scale.Register & Watch
Already a member? Log in now to take advantage of your benefits.
Recro® provides oral solid dosage form development, regulatory support, clinical and commercial manufacturing, and packaging and logistics services to the global pharmaceutical market. Specializing in modified release oral solid dose and DEA controlled substances, Recro has the experts to deliver clients’ most complex pharmaceutical development, manufacturing, and packaging projects in its best-in-class, 120,000-square-foot manufacturing facility. For more information about Recro’s flexible CDMO solutions, visit www.recrocdmo.com.
Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)
Primary business activity
Categories affiliated with Recro
Are you a supplier?
Here's what CPhI Online can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation